Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Full Genetic DNA Data Available in Minutes

By BiotechDaily International staff writers
Posted on 20 May 2013
Image: Close-up view of the microtip probes of the device (Photo courtesy of NanoFacture).
Image: Close-up view of the microtip probes of the device (Photo courtesy of NanoFacture).
A new device can extract human DNA from a swab of saliva, providing full analysis and genome sequencing data within minutes.

Developed by researchers at the University of Washington (UW, Seattle, WA, USA) and NanoFacture (Bellevue, WA, USA), the new device uses microscopic probes that dip into a fluid sample—saliva, sputum, or blood—and apply an electric field within the liquid that attracts particles to concentrate around the surface of the probe. Larger particles hit the tip and swerve away, but DNA-sized molecules stick to the probe and are trapped on the surface via capillary action. It takes two or three minutes to separate and purify DNA using this technology.

The hand-held device can clean four separate human fluid samples at once, but the technology can be scaled up to prepare 96 samples at a time, which is standard for large-scale handling. Engineers at the University of Washington, which developed the technology, have also designed a pencil-sized device using the same probe technology that could be sent home with patients or distributed to those serving in the military overseas. Patients could swab their cheeks, collect a saliva sample, and process their DNA on the spot to send back to hospitals and labs for analysis.

“It’s very complex to extract DNA,” said lead researcher Jae-Hyun Chung, PhD, an associate professor of mechanical engineering at UW. “When you think of the current procedure, the equivalent is like collecting human hairs using a construction crane.”

Conventional methods use a centrifuge to spin and separate DNA molecules or strain them from a fluid sample with a micro-filter, but these processes take 20 to 30 minutes to complete and can require excessive toxic chemicals. The new device will give hospitals and research labs an easier way to separate DNA from human fluid samples, which will help with genome sequencing, disease diagnosis, and forensic investigations.

Related Links:

University of Washington
NanoFacture



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Diagram illustrates the innovative process that could lead to more effective drugs against influenza infection (Photo courtesy of the Hebrew University of Jerusalem).

Researchers Show How the Influenza Virus Blocks Natural Killer Cell Recognition

A team of molecular virologists has described how the influenza virus evolved a defense mechanism to protect it from attack by the immune system's natural killer (NK) cells. The recognition of pathogen-infected... Read more

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.